Reconfirms Revenue and Earnings Guidance for 2008 - Total Revenues Up 28% to $977.3mm for Full Year; Up 27% to $268.0mm for
Fourth Quarter - Adjusted EPS (incl. Stock Compensation) Up 16% to $1.59 for Full Year (GAAP EPS down 11% to $1.46); Up 27% to $0.47 for Fourth Quarter (GAAP EPS
up 62% to $0.47) - Continuing New Win Momentum and Pipeline Strengthening Across Segments - Reconfirming 2008 Revenue Guidance of $1.05 - $1.15 billion and Adjusted
EPS Guidance of $1.80 - $1.90 including Stock Compensation (GAAP EPS
Guidance of $1.78 - $1.88) See note (1) below for an explanation of all non-GAAP financial measures.
All segment information is presented on a comparable basis as if the
Company had operated with four segments since inception.
SOMERSET, N.J., Feb. 28 /PRNewswire-FirstCall/ -- inVentiv Health, Inc.
(Nasdaq: VTIV), a leading provider of commercialization services to the
global pharmaceutical and healthcare industries, today announced record
financial results for the fourth quarter and full year 2007.
Fourth Quarter 2007 Results from Continuing Operations:
-- Total revenues increased 27% to $268.0 million for the fourth quarter
of 2007, compared to $211.8 million for the fourth quarter of 2006.
Net revenues increased 26% to $214.2 million, compared to $170.3
million for the fourth quarter of 2006.
-- Adjusted operating income increased 43% to $31.5 million for the fourth
quarter of 2007, compared to $22.0 million for the fourth quarter of
2006. GAAP operating income increased 75% to $32.3 million for the
|SOURCE inVentiv Health, Inc.|
Copyright©2008 PR Newswire.
All rights reserved